Amit Patel, MD
Hospice and Palliative Medicine · Columbus, OHNPI 1609850049
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.8% of the total across 325 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 27.6% of the total. Among hospice and palliative medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 325 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Medtronic$1K
- Collegium Pharmaceutical, Inc.$680
- Pfizer$351
- Amgen$294
- Biohaven Pharmaceutical Holding Company Ltd.$241
- plus $2K from 28 others
What the payments were for
- Travel & lodging$5619%
- Food & beverage$5,93191%
- Education$411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 115 | $1,806 |
| Medtronic | 20 | $1,294 |
| Collegium Pharmaceutical, Inc. | 42 | $680 |
| Pfizer | 28 | $351 |
| Amgen | 14 | $294 |
| Biohaven Pharmaceutical Holding Company Ltd. | 23 | $241 |
| Boston Scientific | 12 | $198 |
| Biohaven Pharmaceuticals, Inc. | 20 | $192 |
| SPR Therapeutics, Inc | 2 | $182 |
| Galderma Laboratories, L.p. | 1 | $127 |
| Actelion Pharmaceuticals US, Inc. | 1 | $113 |
| Lilly USA, LLC | 7 | $112 |
| Coloplast | 1 | $110 |
| AstraZeneca | 1 | $92 |
| Abbott | 5 | $92 |
| Curonix LLC | 3 | $79 |
| Lundbeck LLC | 3 | $67 |
| Almatica Pharma LLC | 3 | $62 |
| Biodelivery Sciences International, Inc. | 3 | $50 |
| Hikma Pharmaceuticals USA | 3 | $50 |
| Averitas Pharma Inc. | 1 | $46 |
| Vertex | 2 | $45 |
| Orexo US, Inc. | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Nevro Corp. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Indivior Inc. | 1 | $22 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Protega Pharmaceutials Inc | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| Covidien LP | 1 | $15 |
| Forte Bio-pharma LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$280
- INTELLIS ADAPTIVESTIM$164
- SPRINT PNS System$161
- UPTRAVI$113
- OPSUMIT$113
How this compares
$6,532 in reported general payments places this provider in the 95th percentile of 88 hospice and palliative medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 53 | $44,643 |
| OxycontinOxycodone Hcl | 47 | $40,928 |
| UbrelvyUbrogepant | 14 | $22,115 |
| Fentanyl | 77 | $14,252 |
| BelbucaBuprenorphine Hcl | 24 | $13,886 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 408 | $12,404 |
| Oxycodone Hcl | 494 | $9,510 |
| Hysingla ErHydrocodone Bitartrate | 16 | $7,973 |
| Gabapentin | 502 | $7,369 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 348 | $7,306 |
| Pregabalin | 193 | $5,365 |
| Morphine Sulfate ErMorphine Sulfate | 104 | $2,528 |
| Lidocaine | 15 | $2,514 |
| Duloxetine Hcl | 57 | $1,568 |
| Tizanidine Hcl | 117 | $1,531 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $680 | $58,52977 claims |
| AbbVieUbrelvy | $1,806 | $22,11514 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine Hcl | $50 | $1,18132 claims |
| Upsher-smith Laboratories LLCTopiramate | $19 | $20334 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 88 hospice and palliative medicine providers in Ohio.
Other hospice and palliative medicine in Columbus
- Gregory SeidenstickerColumbus$7K
- Michael PattersonColumbus$7K
- Joseph TuColumbus$5K
- Saurabh KhuranaColumbus$3K
- David LaubliColumbus$678
- Jessica MerlinColumbus$550
- Gregg WeidnerColumbus$434
- Tommy PetrosColumbus$431
- Charles MillerColumbus$213
- Kavita ShahColumbus$203
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.